Interpace Biosciences, Inc. (IDXG)
1.798
-0.01
(-0.66%)
USD |
OTCM |
Mar 03, 12:10
Interpace Biosciences Profit Margin (Quarterly) : 11.55% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| FONAR Corp. | 9.94% |
| Thermo Fisher Scientific, Inc. | 16.13% |
| XWELL, Inc. | -2.87% |
| Hypha Labs, Inc. | -- |
| Veracyte, Inc. | 29.26% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 30.26% |
| Return on Invested Capital | 283.2% |
| Gross Profit Margin (Quarterly) | 62.12% |
| Operating Margin (Quarterly) | 13.08% |
| Return on Net Operating Assets | 33.84% |